Mechanistically, given that the activation of TLR3 relies on the signature molecules expressed on pathogens and cancer cells, namely PAMP (pathogen-associated molecular patterns) [9,40], PAMP may be closely associated with the tumorigenicity of TLR3. The gene discussed is TLR3; the disease is cancer.